Protamine/heparin optical nanosensors based on solvatochromism

• Published in: Chemical science (Cambridge) 2021-12, Vol.12 (47), p.15596-1562
• Main Authors: Soda, Yoshiki, Robinson, Kye J, Nussbaum, Robin, Bakker, Eric
• Format: Article
• Language: English
• Subjects: Aqueous environments; Blood plasma; Chemistry; Heparin; Ion exchange; Ions; Nanosensors; Selectivity; Signal transduction
• ISSN: 2041-6520; 2041-6539
• DOI: 10.1039/d1sc04930e

Optical nanosensors for the detection of polyions, including protamine and heparin, have to date relied upon ion-exchange reactions involving an analyte and an optical transducer. Unfortunately, due to the limited selectivity of the available ionophores for polyions, this mechanism has suffered from severe interference in complex sample matrices. To date no optical polyion nanosensors have demonstrated acceptable performance in serum, plasma or blood. Herein we describe a new type of nanosensor based on our discovery of a "hyper-polarizing lipophilic phase" in which dinonylnaphthalenesulfonate (DNNS − ) polarizes a solvatochromic dye much more than even an aqueous environment. We have found that the apparent polarity of the organic phase is only modulated when DNNS − binds to large polyions such as protamine, unlike singly charged ions that lack the cooperative binding required to cause a significant shift in the distribution of the polarizing DNNS − ions. Our new sensing mechanism allows solvatochromic signal transduction without the transducer undergoing ion exchange. The result is significantly improved sensitivity and selectivity, enabling for the first time the quantification of protamine and heparin in human plasma using optical nanosensors that correlates with the current gold standard analysis method, the anti-Xa factor assay. Novel optical nanosensors for the selective detection of the polycationic protamine based on solvatochromic signal change allow one to detect heparin in plasma.